11.02.2015 Views

Global Medical Second Opinion Market (2014-2020)

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

To Enquire About<br />

the Report Click<br />

Here<br />

IndustryARC<br />

<strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> (<strong>2014</strong>-<strong>2020</strong>)<br />

By Disease (Cancer, Cardiac Disorders, Diabetes, Injuries and Others); By Service<br />

Providers (Hospitals, Online and Offline <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> Providers and Health<br />

Insurance Players) & By Geography


To Enquire About<br />

the Report Click<br />

Here<br />

TABLE OF CONTENTS<br />

1. <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Overview<br />

2. Executive Summary<br />

3. <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Landscape<br />

3.1. <strong>Market</strong> share Analysis<br />

3.2. Comparative Analysis<br />

3.2.1. Product Benchmarking<br />

3.2.2. End-User Profiling<br />

3.2.3. Patent Analysis<br />

3.2.4. Top 5 Financial Analysis<br />

4. <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> - <strong>Market</strong> Forces<br />

4.1. <strong>Market</strong> Drivers<br />

4.2. <strong>Market</strong> Constraints<br />

4.3. <strong>Market</strong> Challenges<br />

4.4. Attractiveness of the Industry<br />

4.4.1. Power of Suppliers<br />

4.4.2. Power of Customers<br />

4.4.3. Threat of New entrants<br />

4.4.4. Threat of Substitution<br />

4.4.5. Degree of Competition<br />

5. <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> – Strategic Analysis<br />

5.1. Value Chain Analysis<br />

5.2. Pricing Analysis<br />

5.3. Opportunity Analysis


To Enquire About<br />

the Report Click<br />

Here<br />

5.4. Product Life Cycle Analysis<br />

5.5. Suppliers & Distributors<br />

6. <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> – By Disorders<br />

6.1. Introduction<br />

6.2. Cancer<br />

6.3. Diabetes<br />

6.4. Cardiac disorders<br />

6.5. Neurological disorders<br />

6.6. Ocular disorders<br />

6.7. Pulmonary disorders<br />

6.8. Nephrological disorders<br />

6.9. Allergies<br />

6.10. Injuries<br />

6.11. Others<br />

7. <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> – By Service Providers<br />

7.1. Introduction<br />

7.2. Hospitals<br />

7.3. <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> Providing Companies<br />

7.4. Health Insurance Companies<br />

7.5. Online Services<br />

7.6. Others<br />

8. <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> – By Geography<br />

8.1. Introduction<br />

8.2. Americas


To Enquire About<br />

the Report Click<br />

Here<br />

8.2.1. U.S.<br />

8.2.2. Canada<br />

8.2.3. Brazil<br />

8.2.4. Argentina<br />

8.2.5. Others<br />

8.2.6. Europe<br />

8.2.7. U.K.<br />

8.2.8. Germany<br />

8.2.9. France<br />

8.2.10. Spain<br />

8.2.11. Italy<br />

8.2.12. Others<br />

8.3. APAC<br />

8.3.1. China<br />

8.3.2. Japan<br />

8.3.3. India<br />

8.3.4. Australia<br />

8.3.5. Others<br />

8.4. RoW<br />

8.4.1. Middle East<br />

8.4.2. Africa<br />

9. <strong>Market</strong> Entropy<br />

9.1. New Product Launches<br />

9.2. M&As, Collaborations, Partnerships & JVs


To Enquire About<br />

the Report Click<br />

Here<br />

10. Investment Opportunities<br />

11. Company Profiles<br />

11.1. Advance <strong>Medical</strong><br />

11.2. Mediguide America<br />

11.3. Johns Hopkins USA<br />

11.4. Best Doctors<br />

11.5. Cleveland Clinic<br />

11.6. Bupa <strong>Global</strong><br />

11.7. WorldCare International Inc.<br />

11.8. Grand Rounds<br />

11.9. XMRI.com<br />

11.10. HCA Hospitals<br />

11.11. Penn Medicine<br />

11.12. Cynergy Care<br />

11.13. MediAngels.com<br />

11.14. <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> Pvt. Ltd.<br />

11.15. UC San Diego Health System<br />

11.16. AXA PPP Healthcare<br />

12. Appendix<br />

12.1. Abbreviations<br />

12.2. Sources<br />

12.3. Research Methodology<br />

12.4. Bibliography<br />

12.5. Compilation of Expert Insights


12.6. Disclaimer<br />

To Enquire About<br />

the Report Click<br />

Here


To Enquire About<br />

the Report Click<br />

Here<br />

LIST OF TABLES<br />

Table 1 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> – Pricing Analysis ($)<br />

Table 2 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Disease, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 3 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Cancer, By Service Providers, <strong>2014</strong>-<br />

<strong>2020</strong> ($M)<br />

Table 4 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Cancer, By, By Geography, <strong>2014</strong>-<br />

<strong>2020</strong> ($M)<br />

Table 5 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Diabetes, By Service Providers, <strong>2014</strong>-<br />

<strong>2020</strong> ($M)<br />

Table 6 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Diabetes, By, By Geography, <strong>2014</strong>-<br />

<strong>2020</strong> ($M)<br />

Table 7 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Cardiac disorders, By Service<br />

Providers, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 8 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Cardiac disorders, By, By Geography,<br />

<strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 9 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Neurological disorders, By Service<br />

Providers, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 10 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Neurological disorders, By, By<br />

Geography, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 11 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Ocular disorders, By Service<br />

Providers, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 12 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Ocular disorders, By, By Geography,<br />

<strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 13 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Pulmonary disorders, By Service<br />

Providers, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 14 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Pulmonary disorders, By, By<br />

Geography, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 15 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Nephrological disorders, By Service<br />

Providers, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 16 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Nephrological disorders, By, By<br />

Geography, <strong>2014</strong>-<strong>2020</strong> ($M)


To Enquire About<br />

the Report Click<br />

Here<br />

Table 17 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Allergies, By Service Providers,<br />

<strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 18 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Allergies, By, By Geography, <strong>2014</strong>-<br />

<strong>2020</strong> ($M)<br />

Table 19 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Injuries, By Service Providers, <strong>2014</strong>-<br />

<strong>2020</strong> ($M)<br />

Table 20 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Injuries, By, By Geography, <strong>2014</strong>-<br />

<strong>2020</strong> ($M)<br />

Table 21 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Other disorders, By Service<br />

Providers, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 22 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Other disorders, By, By Geography,<br />

<strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 23 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Service Providers, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 24 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue from Hospitals, By Disease, <strong>2014</strong>-<strong>2020</strong><br />

($M)<br />

Table 25 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue from Hospitals, By, By Geography,<br />

<strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 26 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue from <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong><br />

Providing Companies, By Disease, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 27 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue from <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong><br />

Providing Companies, By, By Geography, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 28 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue from Health Insurance Companies, By<br />

Disease, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 29 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue from Health Insurance Companies, By,<br />

By Geography, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 30 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue from Online Services, By Disease, <strong>2014</strong>-<br />

<strong>2020</strong> ($M)<br />

Table 31 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue from Online Services, By Geography,<br />

<strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 32 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue from Other Service Providers, By<br />

Disease, <strong>2014</strong>-<strong>2020</strong> ($M)


To Enquire About<br />

the Report Click<br />

Here<br />

Table 33 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue from Other Service Providers, By<br />

Geography, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 34 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Geography, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 35 Americas: <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Country, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 36 Americas: <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Disease, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 37 Americas: <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Service Providers, <strong>2014</strong>-<strong>2020</strong><br />

($M)<br />

Table 38 Europe: <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Country, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 39 Europe: <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Disease, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 40 Europe: <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Service Providers, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 41 APAC: <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Country, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 42 APAC: <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Disease, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 43 APAC: <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Service Providers, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 44 RoW: <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Country, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 45 RoW: <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Disease, <strong>2014</strong>-<strong>2020</strong> ($M)<br />

Table 46 RoW: <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Service Providers, <strong>2014</strong>-<strong>2020</strong> ($M)


To Enquire About<br />

the Report Click<br />

Here<br />

LIST OF FIGURES<br />

Figure1 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong>, By Geography, <strong>2014</strong> - <strong>2020</strong> ($M)<br />

Figure2 Segmentation of <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong><br />

Figure3 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Competitive Share Analysis, <strong>2014</strong>(%)<br />

Figure4 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Share, By Disease, <strong>2014</strong> (%)<br />

Figure5 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Share, By Service Providers, <strong>2014</strong> (%)<br />

Figure6 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Share, By Geography, <strong>2014</strong> (%)<br />

Figure7 Americas <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Share, By Country, <strong>2014</strong> (%)<br />

Figure8 Europe <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Share, By Country, <strong>2014</strong> (%)<br />

Figure9 APAC <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Share, By Country, <strong>2014</strong> (%)<br />

Figure10 RoW <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Share, By Country, <strong>2014</strong> (%)<br />

Figure11 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Recent Developments, By Year, 2012-2015


To Enquire About<br />

the Report Click<br />

Here<br />

1. GLOBAL MEDICAL SECOND OPINION MARKET<br />

OVERVIEW<br />

1.1 REPORT SCOPE<br />

The global market for medical second opinion has been segmented by the types of disorders, and<br />

the service providers. The major diseases or conditions the patient seeks medical second opinion are<br />

cancer, diabetes, heart and disorders, diseases pertaining to kidneys and liver, allergies and injuries<br />

resulting from accidents and so on. <strong>Medical</strong> second opinion services are mainly provided by<br />

hospitals, private medical second opinion providing companies, health insurance companies and<br />

online service providers. Each of these segmentations has been studied to give a comprehensive<br />

analysis of the global medical second opinion market.<br />

The overall market has also been presented from the perspective of different geographic locations<br />

into standard geographic regions and key economies for this market. Competitive landscape for each<br />

of the capture technologies and storage methods is highlighted and the market players are profiled<br />

with attributes of company overview, financial overview, business strategies, product portfolio and<br />

recent developments. <strong>Market</strong> shares of the key players for <strong>2014</strong> are provided. The prominent players<br />

profiled in this report are Advance <strong>Medical</strong>, Johns Hopkins USA, Cleveland Clinic, WorldCare<br />

International Inc., AXA PPP Healthcare and others.<br />

The report contains the most detailed and in-depth segmentation and analysis of the global medical<br />

second opinion market during the period <strong>2014</strong> - <strong>2020</strong>.<br />

1.2 STAKEHOLDERS<br />

The following are the prominent stakeholders in the global medical second opinion market.<br />

Hospitals and clinics<br />

Doctors and Healthcare professionals<br />

Ministry of health<br />

Patients<br />

Health insurance players<br />

Laboratories and Diagnostic centres<br />

Online and offline medical second opinion service providers<br />

<strong>Medical</strong> colleges and universities<br />

Regulatory and Legislative bodies


To Enquire About<br />

the Report Click<br />

Here<br />

2. EXECUTIVE SUMMARY<br />

<strong>Medical</strong> second opinion refers to a patient’s act of requesting or seeking evaluation of his health<br />

condition by another physician or specialist to verify and confirm the diagnosis and treatment<br />

prescribed by the previous physician or to know an alternative treatment plan. It is primarily sought<br />

after when the first physician recommends a complex/painful surgery or painful and risky<br />

procedures. The other situations that propel the patient to seek a medical second opinion are when<br />

the patients is not sure of the diagnosis or is unsatisfied with the treatment plans offered by the<br />

primary physician or when it is required by the insurance plan or when the physician himself<br />

recommends to go for it.<br />

The overall global medical second opinion market is currently doing well and is on the rise, which is<br />

estimated to rise to $X billion by <strong>2020</strong>, growing at a CAGR of XX%.<br />

SAMPLE TABLE: GLOBAL MEDICAL SECOND OPINION MARKET, BY REGION,<br />

<strong>2014</strong>-<strong>2020</strong> ($M)<br />

Region <strong>2014</strong> 2015 2016 2017 2018 2019 <strong>2020</strong> CAGR%<br />

(2015-<br />

<strong>2020</strong>)<br />

Americas xx xx xx xx xx xx xx xx%<br />

Europe xx xx xx xx xx xx xx xx%<br />

APAC xx xx xx xx xx xx xx xx%<br />

RoW xx xx xx xx xx xx xx xx%<br />

Total xx xx xx xx xx xx xx xx%<br />

Source: IndustryARC Analysis, Expert Insights<br />

The global market for <strong>Medical</strong> second opinions in <strong>2014</strong> is spread throughout the Americas, Europe,<br />

Asia-Pacific and Rest of the world. Americas occupy the largest market share of xx% in <strong>2014</strong>. The<br />

global market is emerging at a steady pace with increase in the number of patients who are willing to<br />

take health insurance and seeking second opinions for better or alternative treatment or diagnosis.<br />

There have been laws emerging in the favor of patients in the U.S. such as Patient Protection and<br />

Affordable Care Act (PPACA) to enhance the quality and affordability of health insurance reforms<br />

and decrease the costs of healthcare services for individuals. The advances in telemedicine or<br />

mHealth help to close the gaps in healthcare by enabling the doctors to attend patient demands in a<br />

short span of time and eliminate the delays in treatment. The individuals are referring to the internet<br />

and mobile applications for second opinion before undergoing complex procedures, thereby<br />

opening a window of opportunity for medical second opinion services.


To Enquire About<br />

the Report Click<br />

Here<br />

SAMPLE FIGURE: GLOBAL ESTIMATED SHARE OF mHEALTH USERS IN<br />

SMARTPHONES, 2050 (%)<br />

mHEALTH<br />

Source: research2guidance<br />

mHealth refers to the seeking of medical help and information from mobile devices such as smart<br />

phones and tablets through internet and specially developed healthcare mobile applications offered<br />

online. In a survey conducted in U.S., it was discovered that more than 50% of the smartphone<br />

users in the U.S. research from their phone for a second opinion before undergoing treatment for<br />

their respective medical condition. This trend has been growing over the years, owing to the<br />

increasing number of smartphones sold. The soaring number of healthcare apps contributes to this<br />

as well. It is estimated that in 2015, there will be a total of 1,400 million smartphone users all over<br />

the world out of which approximately 500 million users make use of healthcare apps, which enables<br />

the mHealth industry to grow.


To Enquire About<br />

the Report Click<br />

Here<br />

KEY MARKET INSIGHTS<br />

• <strong>Medical</strong> second opinion services provided online are gaining importance and the mHealth<br />

technology is growing at a rapid pace due to advances in technology, enabling the patients to<br />

obtain second opinions without much time lapse.<br />

• According to data collected and published in January, 2015 from MediAngels, almost 44% of the<br />

patients who have been prescribed to undergo a surgery avoided it by seeking a medical second<br />

opinion in India.<br />

• A rising trend has been observed in the medical insurance reforms where the healthcare<br />

insurance companies themselves are propelling their clients to for a medical second opinion in<br />

order to save costs for any treatment or surgery which might not be necessary in the first place.


To Enquire About<br />

the Report Click<br />

Here<br />

12.3 RESEARCH METHODOLOGY<br />

The quantitative and qualitative data collected for the global medical second opinion market<br />

report is from a combination of secondary and primary sources. Research interviews were<br />

conducted with executives and/or mangers in the key product manufacturers and related<br />

organizations. These Key <strong>Opinion</strong> Leaders (KOLs) were then provided a questionnaire to gather<br />

quantitative and qualitative inputs on their operations, performance, strategies and views on the<br />

overall market, including key developments and trends. Data from interviews is consolidated,<br />

checked for consistency and accuracy, and the final market numbers are again validated by<br />

experts. The global medical second opinion market was split by diseases, service providers and<br />

geography based on different factors like primary and secondary sources, understanding of the<br />

number of companies operating in each segment and also KOL insights.<br />

We have used various secondary sources such as directories, articles, white papers, newsletters,<br />

annual reports and paid databases such as OneSource, Hoovers and Factiva to identify and<br />

collect information for extensive commercial study of the global medical second opinion market.<br />

The approach towards finding information regarding the market and forecasting has been quite<br />

extensive. The key players in the market and its value chain were identified through secondary<br />

research and their market opinions were also gathered in a similar way through telephonic<br />

interviews and questionnaires. Interviews with key opinion leaders such as managers and<br />

marketing personnel were used extensively in understanding the need and emergence of medical<br />

second opinion market.<br />

We also have extensive database of contacts which were used to conduct primary interviews and<br />

also to get their inputs using questionnaires.


To Enquire About<br />

the Report Click<br />

Here<br />

THE ARC ADVANTAGE<br />

An analytical model lies at the core of our process, ensuring logical consistency throughout<br />

our research. We complement the model with secondary data and interviews with industry<br />

experts to reflect the latest trends. With our final expert validation, we provide you with<br />

only the most accurate and actionable intelligence.<br />

THE ARC PROCESS<br />

Analytical<br />

Method<br />

Base Method<br />

Consolidation<br />

Method<br />

Delphi<br />

Verification<br />

1. Granular<br />

breakdown of<br />

drivers into<br />

factors<br />

2. Validate all<br />

factors in terms<br />

of their present<br />

impact on the<br />

market<br />

3. Assign weights<br />

to these factors in<br />

terms of their<br />

relevance and<br />

impact on the<br />

market<br />

1. Get a topdown<br />

estimate of<br />

the market<br />

2. Follow it up<br />

with a bottom-up<br />

estimate of the<br />

market<br />

3. Check<br />

forconsistency<br />

and new growth<br />

factors that are<br />

relevant over the<br />

next 10 Years<br />

1. Granular<br />

breakdown of<br />

drivers into<br />

factors<br />

2. Validate all<br />

factors in terms<br />

of their present<br />

impact on the<br />

market.<br />

3. Assign weights<br />

to these factors in<br />

terms of their<br />

relevance and<br />

impact on the<br />

market.<br />

1. Verify the<br />

findings of the<br />

model with<br />

experts from<br />

across the value<br />

chain<br />

2. Verify the<br />

findings with<br />

players across<br />

small and large<br />

enterprises<br />

3. Tweak the<br />

model and add<br />

new factors<br />

4. Build the<br />

Analytical Model<br />

4. Build the Base<br />

model<br />

4. Build the<br />

Consolidated<br />

Model<br />

4. Finalize the<br />

ARC Model<br />

ANALYTICAL MODEL BASE MODEL CONSOLIDATED MODEL ARC MODEL


To Enquire About<br />

the Report Click<br />

Here<br />

ABOUT US<br />

IndustryARC was started by a group of young, passionate professionals along with extensively<br />

experienced industry veterans across various business segments. Our focus and expertise is<br />

mainly in the field of analytics, market research and consulting. Our singular goal is to provide<br />

accurate and affordable research to our clients.<br />

Our research team has expertise in diverse fields like Automotive, Chemicals,Consumer<br />

Product & Services, Electronics, Food & Beverages, Healthcare etc., However diverse the<br />

expertise maybe, everyone in our team shares one common trait - we love data and we love<br />

providing solutions to clients using that data even more! Seeing your business flourish based<br />

on our solutions and strategy is what we love the most!<br />

IndustryARC publishes more than 30 reports on an annual basis in the mentioned Industries.<br />

Our reports are in-depth and high quality reports that can help decision makers frame better<br />

strategies for their business requirements. These reports can be further customized as per your<br />

needs.<br />

Disclaimer:<br />

• The reports sold by IndustryARC are limited publications containing valuable market<br />

information provided to a select group of customers in response to orders.<br />

• Our customers acknowledge and agree that any report bought from IndustryARC is for<br />

their own internal use and not for general publication or disclosure to third parties.<br />

• Our reports or part of the reports, information contained in the report, cannot be<br />

shared or resold to any other third party.<br />

• Disclosure to third parties, usage of data in a public document, article or blog by the<br />

customer can be done with prior permission taken from IndustryARC.<br />

For information regarding permissions and sales, contact:<br />

sales@industryarc.com | sanjay.matthews@industryarc.com


To Enquire About<br />

the Report Click<br />

Here<br />

IndustryARC<br />

+1 614 - 588 - 8538<br />

sales@industryarc.com<br />

Copyright ©2015 IndustryARC<br />

All Rights Reserved. This document contains highly confidential information and is the sole<br />

property of IndustryARC. No part of it may be circulated, copied, quoted, or otherwise reproduced<br />

without the approval of IndustryARC.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!